BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4790696)

  • 1. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
    Hellström I; Warner GA; Hellström KE; Sjögren HO
    Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
    [No Abstract]   [Full Text] [Related]  

  • 2. The halo naevus and malignant melanoma.
    Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
    Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
    Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
    [No Abstract]   [Full Text] [Related]  

  • 4. Halo nevus: competent surveillance of potential melanoma?
    Krebs JA; Roenigk HH; Deodhar SD; Barna B
    Cleve Clin Q; 1976; 43(1):11-5. PubMed ID: 1261030
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological associations of the halo naevus with cutaneous malignant melanoma.
    Copeman PW; Lewis MG; Phillips TM; Elliott PG
    Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
    Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
    Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.
    Levy NL; Mahaley MS; Day ED
    Int J Cancer; 1972 Sep; 10(2):244-8. PubMed ID: 4661092
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane markers of lymphocytes in lymphomas, melanoma and lupus erythematosus.
    Edelson RL
    Int J Dermatol; 1976 Oct; 15(8):577-86. PubMed ID: 786913
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
    Mitchell MS; Nordlund JJ; Lerner AB
    J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte stimulation in the cellular inflammatory reaction of some human skin tumours.
    Pullmann H; Steigleder GK
    Arch Dermatol Res (1975); 1975 Oct; 253(3):219-24. PubMed ID: 1200701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic analysis of tyrosinase in malignant melanoma, nevi and clinically normal skin].
    Herrmann WP
    Arch Dermatol Forsch; 1971; 241(1):65-74. PubMed ID: 4997883
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses induced by human malignant melanoma in the rabbit.
    Goodwin DP; Hornung MO; Leong SP; Krementz ET
    Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract]   [Full Text] [Related]  

  • 16. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of human malignant melanoma.
    Lewis MG
    Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of circulating antibody in the control of metastases.
    Lewis MG
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():83-93. PubMed ID: 4598354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV; Korosteleva TA
    Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.